Avanos Medical, Inc. (AVNS) has a MoatMap StockRank of 84/100 based on Quality (51/100), Value (34/100), and Momentum (84/100) factor scores. The current signal is STRONG BUY. A medical device company undergoing a multi-year business transition with weak historical organic growth, failing the Terry Smith quality compounder filter.
Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior solutions for patient recovery, with products for pain management, respiratory health, and digestive health. The company holds established positions in niche medical device markets through its clinically differentiated products and strong relationships with healthcare providers, providing a competitive edge and resilient demand.
| Price | $25.03 |
| Market Cap | $1.2B |
| P/E (Forward) | 20.00 |
| Price/Book | 1.49 |
| Return on Equity | -9.2% |
| Return on Invested Capital | -6.4% |
| Debt/Equity | 17.70 |
| Gross Margin | 50.0% |
| Operating Margin | 5.4% |
| Revenue Growth | 8.8% |
| Free Cash Flow | $17M |
Avanos Medical, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).